Testosterone Replacement Therapy Market, Size, Share, Opportunities and Forecast, 2020-2027

Global Testosterone Replacement Therapy Market is segmented By Product Type (Oral Implants, Injections, Patches, Creams/Gels, Gums/Buccal Adhesives), By Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Testosterone Replacement Therapy Market is expected to grow at a high CAGR during the forecasting period (2020-2027).

Testosterone Replacement Therapy Market expected to reach USD 1.3 billion by 2026

• Testosterone Replacement Therapy (TRT) or androgen replacement therapy is a type of hormone replacement therapy in which androgens, often testosterone, are replaced.

• TRT is an FDA-approved medical treatment for men of any age who have low testosterone, the primary male sex hormone.

• The global market for Testosterone Replacement Therapy is estimated to reach USD 1.3 billion by 2026.

Market Outlook

• Primary market drivers include the rise in the incidence of testosterone deficiency, increase in geriatric population with high risk of testosterone deficiency and increasing awareness about testosterone substitute therapy.

• However, the high risk of side effects associated with testosterone replacement therapy will restrain market growth.

• Testosterone use is possibly associated with an increased risk of developing cardiovascular disease and prostate cancer.

• However, the market is continuing to decline due to strict FDA warnings regarding the use of testosterone drugs.

Market Segmentation

• The global Testosterone Replacement Therapy market report segments the market by product type, by active ingredient, and by region.

• Based on product type, the TRT market is segmented into oral, implants, gums/ buccal adhesives, injections, patches, and creams/ gels.

• Creams/gels segment accounted for the largest share with approximately 66% as they are available in a semi-solid form and can be applied quickly and removed. Also, they contain an active ingredient which can be applied locally for maximum efficacy.

• Based on lines of its active ingredient, the market is divided into five categories: testosterone, testosterone cypionate, testosterone enanthate, testosterone undecanoate, and methyltestosterone.

Key Segments Covered

By Product Type

• Oral

• Implants

• Gums/Buccal Adhesives

• Injections

• Patches

• Creams/Gels

By Active Ingredient Type

• Testosterone

• Testosterone Cypionate

• Testosterone Enanthate

• Testosterone Undecanoate

• Methyl Testosterone

By Region

• Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

• Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

• North America (The USA, Canada, Mexico)

• South America (Brazil, Argentina, Rest of South America)

• Rest of the World

Geographical Analysis

• Geographically, the market is segmented into five major regions: North America, South America, Europe, Asia Pacific, and RoW.

• North America dominates the market for Testosterone Replacement Therapy, with the US being the largest market.

• The use of testosterone therapy is widespread in the US, with an estimated 2.3 million American men receiving treatment in 2013.

Competitive Trends

• The report also profiles the following companies in Testosterone Replacement Therapy market – AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc.

Why purchase the report?

• Visualize the composition of Testosterone Replacement Therapy market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.

• Identify commercial opportunities by analyzing trends and co-development deals.

• Excel data sheet with thousands of data points of the market – level 4/5 segmentation.

• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

• Product mapping in excel for crucial Testosterone Replacement Therapy of all major market players

Target Audience

• Equipment Suppliers/ Buyers

• Service Providers/ Buyers

• Industry Investors/Investment Bankers

• Education & Research Institutes

• Research Professionals

• Emerging Companies

• Manufacturers

 

Table of Contents

1. Testosterone Replacement Therapy Market – Methodology and Scope

1.1. Research Methodology

1.2. Scope of the Report

2. Testosterone Replacement Therapy Market Trends

2.1. Key Trends & Developments

3. Testosterone Replacement Therapy – Industry Analysis

3.1. Market Drivers

3.1.1. Rise in incidence of testosterone deficiency

3.1.2. Increase in geriatric population with high risk of testosterone deficiency

3.1.3. Increasing awareness about testosterone substitute therapy

3.2. Market Restraint 

3.2.1. High risk of side effects associated to testosterone replacement therapy

3.3. Threats and Opportunities

3.4. Porter’s Forces

4. Testosterone Replacement Therapy Market Segmentation

4.1. By Product Type

4.1.1. Oral Implants

4.1.2. Gums/Buccal Adhesives

4.1.3. Injections

4.1.4. Patches

4.1.5. Creams/Gels

4.2. By Active Ingredient

4.2.1. Testosterone

4.2.2. Testosterone Cypionate

4.2.3. Testosterone Enanthate

4.2.4. Testosterone Undecanoate

4.2.5. Methyl Testosterone

5. Testosterone Replacement Therapy Market – Geographical Analysis

5.1. North America

5.1.1. The USA

5.1.2. Canada

5.1.3. Mexico

5.2. Europe

5.2.1. Germany

5.2.2. France

5.2.3. The UK

5.2.4. Italy

5.2.5. Spain

5.2.6. Rest of Europe

5.3. Asia Pacific

5.3.1. China

5.3.2. Japan

5.3.3. India

5.3.4. Australia

5.3.5. Rest of Asia Pacific

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. Rest of the World

6. Testosterone Replacement Therapy Market – Competitive Landscape

6.1. Market Share Analysis

6.2. Mergers and Acquisitions Analysis

6.3. New Product Launches

 7. Testosterone Replacement Therapy Market – Company Profiles

7.1. AbbVie, Inc.

7.2. Allergan plc

7.3. Bayer AG

7.4. Endo Pharmaceuticals, Inc.

7.5. Eli Lilly and Company

7.6. Kyowa Kirin International Plc

7.7. Mylan N.V.

7.8. Novartis AG

7.9. Pfizer, Inc.

8. Testosterone Replacement Therapy Market – Appendix

8.1. Sources

8.2. List of Tables

8.3. Expert Panel Validation

8.4. Disclaimer

8.5. Contact Us